Both in Pharmaceuticals
Lifevantage Corporation Common Stock (Delaware) vs Aldeyra Therapeutics
Over the past year LFVN returned −35.2% and ALDX returned −74.7%; their daily moves had a correlation of 0.11.
LFVN −35.2% ALDX −74.7%Growth of $1, one year, split-adjusted
| Metric | LFVN | ALDX |
|---|---|---|
| Price | $6.32 | $1.32 |
| Market cap | $79.6M | $79.6M |
| Today | +2.10% | +13.79% |
| 1 month | −0.6% | −11.1% |
| 6 months | +43.6% | −21.4% |
| Year to date | +2.6% | −74.5% |
| 1 year | −38.0% | −74.0% |
| Revenue growth (YoY) | −23.1% | — |
| Gross margin | 78.0% | — |
| Net margin | 3.0% | — |
| P/E (TTM) | 15.7× | — |
| Price / sales | 0.4× | — |
| Net cash | $14.9M | $45.1M |
| Dividend yield | 3.16% | — |
| Volatility (60d) | 27.4% | 69.9% |
| Short % of float | 11.5% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).